Coagulation defects caused by diphenylhydantoin.
D000818:Animals; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000188:drug therapy; D001779:Blood Coagulation Factors; D002415:Cats; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008431:Maternal-Fetal Exchange; D010672:Phenytoin / Q000009:adverse effects* / Q000494:pharmacology; D011247:Pregnancy; D011517:Prothrombin Time; D013925:Thromboplastin / Q000032:analysis; D014812:Vitamin K / Q000627:therapeutic use; D014859:Warfarin / Q000494:pharmacology
D001779:Blood Coagulation Factors; D014812:Vitamin K; D014859:Warfarin; D010672:Phenytoin; D005165:Factor V; D005167:Factor VII; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D013925:Thromboplastin